LifeMD (LFMD) Common Equity (2012 - 2025)

LifeMD's Common Equity history runs 14 years deep, the most recent figure standing at $23.2 million for Q4 2025.

• Quarterly Common Equity rose 354.94% year-over-year to $23.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.2 million (up 354.94% YoY) and the FY2025 annual result came in at $23.2 million, up 354.94% from the prior year.
• Common Equity was $23.2 million for Q4 2025 at LifeMD, up from $1.3 million in the prior quarter.
• Across five years, Common Equity topped out at $23.2 million in Q4 2025 and bottomed at -$240.8 million in Q1 2025.
• A 5-year average of -$13.3 million and a median of -$1.6 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity jumped 1541.84% — and 2025, when it plunged 10163.36%.
• LifeMD's Common Equity stood at $21.7 million in 2021, then sank by 154.69% to -$11.9 million in 2022, then surged by 135.29% to $4.2 million in 2023, then plunged by 316.83% to -$9.1 million in 2024, then jumped by 354.94% to $23.2 million in 2025.
• Business Quant data shows LFMD's Common Equity at $23.2 million in Q4 2025, $1.3 million in Q3 2025, and $2.3 million in Q2 2025.